ArticleTranslational andrology and urology2025
Effect of prostate volume on the predictive value of prostate-specific antigen density for prostate cancer.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making.European radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In clinical practice, we observed that some patients with larger prostate volume (PV) and prostate-specific antigen (PSA) values below 20 ng/mL still yielded negative biopsy results. We aim to establish a more precise volume range for guiding biopsies in patients with enlarged prostate glands. Methods: We conducted a retrospective analysis of 424 cases involving patients who underwent prostate biopsy. The patients were categorized into three groups based on their body mass index: small (PV <45 cm Results: In the multivariate logistic regression analysis, a statistically significant association was observed between prostate-specific antigen density (PSAD) ≥0.15 ng/mL/cm Conclusions: The likelihood of developing prostate cancer is higher in patients with small PVs (PV <45 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.